These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 16173953
1. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat. Calama E, Ortíz de Urbina AV, Morán A, Martín ML, San Román L. Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953 [Abstract] [Full Text] [Related]
2. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart. García M, Morán A, Martín ML, Ortizde Urbina AV, San Román L. Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377 [Abstract] [Full Text] [Related]
3. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat. Calama E, Fernández MM, Morán A, Martín ML, San Román L. Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496 [Abstract] [Full Text] [Related]
4. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Calama E, Morán A, Ortiz de Urbina AV, Martín ML, San Román L. Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345 [Abstract] [Full Text] [Related]
5. m-CPP, a 5-HT2C receptor agonist that modifies the perfusion pressure of the hindquarter vascular bed of anesthetized rat. Calama E, Morán A, Ortiz de Urbina AV, Martín ML, San Román L. Pharmacology; 2005 Feb; 73(2):70-5. PubMed ID: 15452415 [Abstract] [Full Text] [Related]
6. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery. Geerts IS, Matthys KE, Herman AG, Bult H. Br J Pharmacol; 1999 Jul; 127(6):1327-36. PubMed ID: 10455282 [Abstract] [Full Text] [Related]
7. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats. Restrepo B, García M, Rodríguez-Barbero A, Román LS, Martin ML, Morán A. Eur J Pharmacol; 2011 May 20; 659(1):37-44. PubMed ID: 21414306 [Abstract] [Full Text] [Related]
8. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats. García-Pedraza JÁ, García M, Martín ML, Morán A. Vascul Pharmacol; 2015 Sep 20; 72():172-80. PubMed ID: 26003124 [Abstract] [Full Text] [Related]
9. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation. Fernández MM, Morán A, Martín ML, San Román L. Eur J Pharmacol; 2000 Aug 04; 401(2):221-7. PubMed ID: 10924930 [Abstract] [Full Text] [Related]
10. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium. Molderings GJ, Frölich D, Likungu J, Göthert M. Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb 04; 353(3):272-80. PubMed ID: 8692281 [Abstract] [Full Text] [Related]
11. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature. García-Pedraza JA, García M, Martín ML, Rodríguez-Barbero A, Morán A. Vascul Pharmacol; 2016 Apr 04; 79():51-59. PubMed ID: 26586311 [Abstract] [Full Text] [Related]
12. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors. García-Pedraza JÁ, García-Domingo M, Gómez-Roso M, Rodríguez-Barbero A, Martín ML, Morán A. Clin Exp Pharmacol Physiol; 2017 Dec 04; 44(12):1224-1231. PubMed ID: 28771848 [Abstract] [Full Text] [Related]
13. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Nilsson T, Longmore J, Shaw D, Pantev E, Bard JA, Branchek T, Edvinsson L. Eur J Pharmacol; 1999 May 07; 372(1):49-56. PubMed ID: 10374714 [Abstract] [Full Text] [Related]
14. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat. Morán A, Fernández MM, Velasco C, Martín ML, San Román L. Br J Pharmacol; 1998 Mar 07; 123(6):1205-13. PubMed ID: 9559906 [Abstract] [Full Text] [Related]
15. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex. Bühlen M, Fink K, Böing C, Göthert M. Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb 07; 353(3):281-9. PubMed ID: 8692282 [Abstract] [Full Text] [Related]
16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ, Bervoets K, Colpaert FC. J Pharmacol Exp Ther; 1991 Mar 07; 256(3):973-82. PubMed ID: 1826033 [Abstract] [Full Text] [Related]
17. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors. Sánchez-Lopez A, Centurión D, Vázquez E, Arulmani U, Saxena PR, Villalón CM. Br J Pharmacol; 2003 Oct 07; 140(4):725-35. PubMed ID: 14504136 [Abstract] [Full Text] [Related]
18. Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat. García M, Morán A, Calama E, Martín ML, Barthelmebs M, Román LS. Br J Pharmacol; 2005 Jul 07; 145(5):593-601. PubMed ID: 15852039 [Abstract] [Full Text] [Related]
19. 5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta. Siddiqui A, Abu-Amara M, Aldairy C, Hagan JJ, Wilson C. Eur J Pharmacol; 2004 Apr 26; 491(1):77-84. PubMed ID: 15102536 [Abstract] [Full Text] [Related]
20. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs. Villalón CM, Ramírez-San Juan E, Castillo C, Castillo E, López-Muñoz FJ, Terrón JA. Br J Pharmacol; 1995 Nov 26; 116(6):2778-84. PubMed ID: 8591004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]